Table 1 Association (odds ratio, OR, with 95% confidence interval, CI) of low avidity HPV16 antibodies (ab) with increased risk of being seropositive for other HPV types among Finnish and Ugandan women.
Population | Seropositivity | Total | Prevalence of low ab-avidity (%) | Crude OR (95% CI) |
|---|---|---|---|---|
Finland (n = 248) | HPV16 only | 113 | 19 (7.7%) | 1 |
HPV16 + 6 or 11 | 36 | 8 (6.3%) | 1.4 (0.6-3.6) | |
HPV16 + 31 or 33 | 59 | 5 (2.5%) | 0.5 (0.2-1.3) | |
HPV16 + 18 or 45 | 40 | 6 (2.2%) | 0.9 (0.3-2.4) | |
Uganda (n = 117) | HPV16 only | 45 | 9 (7.7%) | 1 |
HPV16 + 6 or 11 | 32 | 15 (12.8%) | 3.5 (1.3-9.7) | |
HPV16 + 31 or 33 | 24 | 4 (3.4%) | 0.8 (0.2-2.9) | |
HPV16 + 18 or 45 | 16 | 2 (1.7%) | 0.6 (0.1-4.0) | |
All (n = 365) | HPV16 only | 158 | 28 (7.7%) | 1 |
HPV16 + 6 or 11 | 68 | 23 (6.3%) | 2.4 (1.3-4.6) | |
HPV16 + 31 or 33 | 83 | 9 (2.5%) | 0.6 (0.3-1.3) | |
HPV16 + 18 or 45 | 56 | 8 (2.2%) | 0.8 (0.3-1.8) |